(S)-(+)-1-甲氧基-2-丙醇 | 26550-55-0

• 物质功能分类: 有机原料 - 醇、酚、酚醇类化合物及衍生物 - 无环醇
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: (S)-(+)-1-甲氧基-2-丙醇
• 中文别名: S-(+)-1-甲氧基-2-丙醇
• 英文名称: (S)-1-Methoxy-propan-2-ol
• 英文别名: (S)-(+)-1-methoxy-2-propanol；(2S)-1-methoxypropan-2-ol
• CAS: 26550-55-0
• 化学式: C₄H₁₀O₂
• 分子量: 90.1222
• InChiKey: ARXJGSRGQADJSQ-BYPYZUCNSA-N

物化性质

• 熔点：
  -84.2°C (estimate)
• 沸点：
  118-119 °C
• 比旋光度：
  20 º (c=10, CHCl3)
• 密度：
  0.921 g/mL at 20 °C (lit.)
• 闪点：
  33 °C
• 溶解度：
  氯仿（微溶）、甲醇（微溶）
• 稳定性/保质期：
  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  6
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  3
• 危险品标志：
  F
• 安全说明：
  S24,S43,S7/8
• 危险类别码：
  R10
• WGK Germany：
  3
• 海关编码：
  2909499000
• 危险品运输编号：
  UN 3092
• 包装等级：
  III
• 危险类别：
  3
• 危险性防范说明：
  P501,P240,P210,P233,P243,P241,P242,P280,P370+P378,P303+P361+P353,P403+P235
• 危险性描述：
  H225
• 储存条件：
  存于阴凉干燥处

SDS

Name:	(S)-(+)-1-Methoxy-2-propanol Material Safety Data Sheet
Synonym:
CAS:	26550-55-0

Section 1 - Chemical Product MSDS Name:(S)-(+)-1-Methoxy-2-propanol Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
26550-55-0	(S)-(+)-1-Methoxy-2-propanol		unlisted

Hazard Symbols: None Listed.
Risk Phrases: 10

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Flammable.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Remove contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Get medical aid immediately. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Flammable liquid and vapor.
Extinguishing Media:
Use agent most appropriate to extinguish fire.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Clean up spills immediately, observing precautions in the Protective Equipment section.

---

Section 7 - HANDLING and STORAGE
Handling:
Empty containers retain product residue, (liquid and/or vapor), and can be dangerous. Keep away from heat, sparks and flame.
Storage:
Keep away from heat, sparks, and flame.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Exposure Limits CAS# 26550-55-0: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves and clothing to prevent skin exposure. Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to minimize contact with skin.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use. Wear a NIOSH/MSHA or European Standard EN 149 approved full-facepiece airline respirator in the positive pressure mode with emergency escape provisions.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 118 - 119 deg C @ 7
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 33 deg C ( 91.40 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: .9220g/cm3
Molecular Formula: CH3OCH2CH(OH)CH3
Molecular Weight: 90.12

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources.
Incompatibilities with Other Materials:
Oxidizing agents, acid chlorides.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 26550-55-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(S)-(+)-1-Methoxy-2-propanol - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: 1-METHOXY-2-PROPANOL
Hazard Class: 3
UN Number: 3092
Packing Group: III
IMO
Shipping Name: 1-METHOXY-2-PROPANOL
Hazard Class: 3
UN Number: 3092
Packing Group: III
RID/ADR
Shipping Name: 1-METHOXY-2-PROPANOL
Hazard Class: 3
UN Number: 3092
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
R 10 Flammable.
Safety Phrases:
S 24 Avoid contact with skin.
WGK (Water Danger/Protection)
CAS# 26550-55-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 26550-55-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 26550-55-0 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

(S)-(+)-1-甲氧基-2-丙醇可以作为有机合成中间体和医药中间体，主要应用于实验室研发和化工生产的各个环节。

反应信息

• 作为反应物：
  描述：

  (S)-(+)-1-甲氧基-2-丙醇 在 水 、 三氯氧磷 作用下， 生成 phosphoric acid mono-((S)-β-methoxy-isopropyl ester)
  参考文献：
  名称：

  The Lanthanum Hydroxide Gel Promoted Hydrolysis of Phosphate Esters

  摘要：

  DOI：

  10.1021/ja01614a018
• 作为产物：
  描述：

  丙二醇甲醚 生成 (S)-(+)-1-甲氧基-2-丙醇
  参考文献：
  名称：

  The Lanthanum Hydroxide Gel Promoted Hydrolysis of Phosphate Esters

  摘要：

  DOI：

  10.1021/ja01614a018

文献信息

• [EN] BENZIMIDAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS<br/>[FR] DÉRIVÉS DE BENZIMIDAZOLE COMME INHIBITEURS DES BROMODOMAINES
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2016146738A1

  公开（公告）日：2016-09-22

  Compounds of formula (I) and salts thereof: wherein R1, R2, R3, R4 are defined herein. Compounds of formula (I) and salts thereof have been found to inhibit the binding of the BET family of bromodomain proteins to, for example, acetylated lysine residues and thus may have use in therapy, for example in the treatment of autoimmune and inflammatory diseases, such as rheumatoid arthritis; and cancers.

  式（I）的化合物及其盐：其中R1、R2、R3、R4在此处定义。已发现式（I）的化合物及其盐能够抑制BET家族的溴结构域蛋白与例如乙酰化赖氨酸残基的结合，因此可能在治疗中发挥作用，例如在治疗自身免疫和炎症性疾病（如类风湿性关节炎）和癌症方面。
• [EN] FUSED PYRAZOLE DERIVATIVES AS JAK INHIBITORS<br/>[FR] DÉRIVÉS DE PYRAZOLE CONDENSÉS UTILISÉS EN TANT QU'INHIBITEURS DE JAK
  申请人：ALMIRALL SA

  公开号：WO2017220431A1

  公开（公告）日：2017-12-28

  Novel fused pyrazole derivatives of Formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).

  公开了式（I）的新型融合吡唑衍生物；以及它们的制备方法，包含它们的药物组合物以及它们作为Janus激酶（JAK）抑制剂在治疗中的用途。
• Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
  申请人：AbbVie S.à.r.l.

  公开号：US20190077784A1

  公开（公告）日：2019-03-14

  The invention discloses compounds of Formula (I), wherein A 1 , R 1 , R 2 , R 3 , R 4 , and n are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.

  该发明揭示了式（I）的化合物， 其中A 1 ，R 1 ，R 2 ，R 3 ，R 4 和n如本文所定义。本发明涉及化合物及其在囊性纤维化治疗中的应用，其生产方法，包含相同化合物的药物组合物，以及通过给予该发明的化合物来治疗囊性纤维化的方法。
• [EN] MAP4K4 INHIBITORS<br/>[FR] INHIBITEURS DE MAP4K4
  申请人：IMPERIAL INNOVATIONS LTD

  公开号：WO2019073253A1

  公开（公告）日：2019-04-18

  This invention relates to pyrrolopyrimidine comprising compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these pyrrolopyrimidine comprising compounds, for example in a method of treatment. There are also provided processes for producing compounds of the present invention and method of their use. In particular, the present invention relates to compounds of formula (I).

  这项发明涉及含有吡咯吡嘧啶的化合物，这些化合物可能作为丝裂原活化蛋白激酶激酶激酶激酶-4（MAP4K4）的抑制剂而有用。该发明还涉及利用这些含有吡咯吡嘧啶的化合物，例如在治疗方法中的使用。还提供了生产本发明化合物的方法以及它们的使用方法。具体而言，本发明涉及式（I）的化合物。
• Stereocontrolled C(sp³)–P bond formation with non-activated alkyl halides and tosylates
  作者：Chu-Ting Yang、Jun Han、Jun Liu、Yi Li、Fan Zhang、Mei Gu、Sheng Hu、Xiaolin Wang

  DOI：10.1039/c7ra02766d

  日期：——

  The C(sp3)–P bond is formed via the reaction between P–H compounds and non-activated alkyl electrophiles, especially secondary alkyl halides and tosylates. This reaction proceeds via an SN2 mechanism with inversion of configuration, so it can be used to form C–P bonds with stereocontrol from chiral secondary alcohols.

  C（sp 3）-P键是通过P–H化合物与未活化的烷基亲电试剂（特别是仲烷基卤化物和甲苯磺酸酯）之间的反应形成的。该反应通过具有反转构型的S N 2机理进行，因此可以用于从手性仲醇的立体控制下形成C-P键。